- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer after Radical Prostatectomy.Prostate CancerAugust 2, 2021
-
An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer.Prostate CancerAugust 2, 2021
-
177Lutetium PSMA-617 and idronoxil (NOX66) in men with end-stage metastatic castrate-resistant prostate cancer (LuPIN): Patient outcomes and predictors of treatment response of a Phase I/II trial.Prostate CancerAugust 2, 2021
-
Activation of the ABCB1-amplicon promotes cellular viability and resistance to docetaxel and cabazitaxel in castration-resistant prostate cancer.Prostate CancerAugust 2, 2021
-
A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: Results from a prospective multi-center study in 2005 patients.Prostate CancerAugust 2, 2021
-
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.Prostate CancerAugust 2, 2021
-
Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy.Prostate CancerJuly 30, 2021
-
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study.Prostate CancerJuly 30, 2021
-
Robotic-assisted radical prostatectomy with the Senhance® robotic platform: single center experience.Prostate CancerJuly 30, 2021
-
Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer.Prostate CancerJuly 30, 2021
Beyond the Abstracts
-
Prognostic Value of Testosterone Castration Levels Following Androgen Deprivation and High-Dose Radiotherapy in Localized Prostate Cancer: Results from a Phase III Trial - Beyond the AbstractProstate CancerJuly 27, 2021
-
Survival Advantage of Asian Metastatic Prostate Cancer Patients Treated with External Beam Radiotherapy over Other Races/ethnicities - Beyond the AbstractProstate CancerJuly 26, 2021
-
Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study - Beyond the AbstractProstate CancerJuly 7, 2021
-
Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study - Beyond the AbstractProstate CancerJune 28, 2021
-
What’s Important for Improving Biopsy Acquisition, Is Lesion Selection a Key? A Specialized, Web-Based Naing Tool for Target Lesion Selection - Beyond the AbstractProstate CancerJune 23, 2021
-
Attenuation of SRC Kinase Activity Augments PARP Inhibitor-Mediated Synthetic Lethality in BRCA2-Altered Prostate Tumors - Beyond the AbstractProstate CancerJune 18, 2021
-
Overall Survival of Men with Metachronous Metastatic Hormone-Sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy - Beyond the AbstractProstate CancerJune 1, 2021
-
PHI Density Prospectively Improves Prostate Cancer Detection - Beyond the AbstractProstate CancerMay 25, 2021
-
Phase 3 Multicenter Randomized Trial of PSMA PET/CT Prior to Definitive Radiation Therapy for Unfavorable Intermediate-Risk or High-Risk Prostate Cancer [PSMA dRT]: Study Protocol - Beyond the AbstractProstate CancerMay 21, 2021
-
MRI Predicts Prostatic Urethral Involvement in Men Undergoing Radical Prostatectomy: Implications for Cryo-Ablation of Localized Prostate Cancer - Beyond the AbstractProstate CancerMay 17, 2021